In vitro efficacy of a synthetic all-d antimicrobial peptide against clinically isolated drug-resistant strains

International Journal of Antimicrobial Agents

Volumn 35, Issue 2, 2010, Pages 208-209

  Park, Yoonkyung ^a   Park, Seong Cheol ^a   Kim, Jin Young ^a   Park, Jeong Ok ^b   Seo, Chang Ho ^b   Nah, Jae Woon ^c   Hahm, Kyung Soo ^a  

^a Chosun University   (South Korea)

^b Kongju National University   (South Korea)

^c Sunchon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DEXTRO LYSYLTRYPTOPHYLLYSYLLYSYLLEUCYLLEUCYLLYSYLLYSYLPROLYLLEUCYLLEUCYLLYSYLLYSYLLEUCYLLEUCYLLYSYLLYSYLLEUCINE AMIDE; LYSYLTRYPTOPHYLLYSYLLYSYLLEUCYLLEUCYLLYSYLLYSYLPROLYLLEUCYLLEUCYLLYSYLLYSYLLEUCYLLEUCYLLYSYLLYSYLLEUCINE AMIDE; MAGNESIUM CHLORIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG SCREENING; ESCHERICHIA COLI; HUMAN; IN VITRO STUDY; IONIC STRENGTH; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; FEMALE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; RECOMBINANT FUSION PROTEINS; REPUBLIC OF KOREA; XENOPUS PROTEINS;

EID: 72449121459     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.10.010     Document Type: Letter

References (7)

1. Andrä J., Berninghausen O., and Leippe M. Cecropins, antibacterial peptides from insects and mammals, are potently fungicidal against Candida albicans. Med Microbiol Immunol 189 (2001) 169-173
2. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84 (1987) 5449-5453
3. Boman H.G. Antibacterial peptides: key components needed in immunity. Cell 65 (1991) 205-207
4. Bush K., Macielag M., and Weidner-Wells M. Taking inventory: antibacterial agents currently at or beyond phase I. Curr Opin Microbiol 7 (2004) 466-476
5. Park Y., Lee D.G., Jang S.H., Woo E.R., Jeong H.G., Choi C.H., et al. A Leu-Lys-rich antimicrobial peptide: activity and mechanism. Biochim Biophys Acta 1645 (2003) 172-182
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 5th ed. Document M7-A5. Wayne, PA: NCCLS; 2000.
7. Powell M.F., Grey H., Gaeta F., Sette A., and Colón S. Peptide stability in drug development: a comparison of peptide reactivity in different biological media. J Pharm Sci 81 (1992) 731-735